Active Pharmaceutical Ingredient (API)
Paclitaxel
Cytotoxic Chemotherapy (Taxane)
A major taxane chemotherapy drug used against breast, ovarian, and lung cancers. It disrupts cell division by stabilizing the microtubules, preventing their breakdown and thus arresting the cell in the $\text{M}$ phase of the cell cycle. Its formulation often requires special vehicles due to its poor water solubility.
Technical Profile
- Reference Code
- PAC217
- CAS Number
- 33069-62-4
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Paclitaxel as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Paclikwal 100 G | Kwality Pharmaceuticals Ltd | Injection (100 mg) | ₹2,100.00 | View Details |
| Altaxel 100 G | Alkem Laboratories Ltd | Injection (100 mg) | ₹3,200.00 | View Details |
| Altaxel Nova 100 G | Alkem Laboratories Ltd | Injection (100 mg) | ₹2,450.00 | View Details |
| Paclicad 100 G | Beta Drugs Ltd | Injection (100 mg) | ₹3,000.00 | View Details |
| Adpax 300 G | Beta Drugs Ltd | Injection (300 mg) | ₹11,500.00 | View Details |
| Z-Taxel 260 G | Zee Laboratories (OncoZest) | Injection (260 mg) | ₹4,850.00 | View Details |
| Pacliwel 300 H | Getwell Oncology | Injection (300 mg) | ₹12,060.00 | View Details |
| Pacliwel 100 H | Getwell Oncology | Injection (100 mg) | ₹3,850.00 | View Details |